Nathaniel Mosley1, Joon Y Chung1, Gina Jin1, Maria A Franceschini2, Michael J Whalen1, David Y Chung3,4. 1. Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 2. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA. 3. Neurovascular Research Unit, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 149 13th St, Charlestown, MA, 02129, USA. dychung@mgh.harvard.edu. 4. Division of Neurocritical Care, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA, 02114, USA. dychung@mgh.harvard.edu.
Abstract
BACKGROUND: Cortical spreading depolarizations (CSDs) are associated with worse outcomes in many forms of acute brain injury, including traumatic brain injury (TBI). Animal models could be helpful in developing new therapies or biomarkers to improve outcomes in survivors of TBI. Recently, investigators have observed CSDs in murine models of mild closed head injury (CHI). We designed the currently study to determine additional experimental conditions under which CSDs can be observed, from mild to relatively more severe TBI. METHODS: Adult male C57Bl/6J mice (8-14 weeks old) were anesthetized with isoflurane and subjected to CHI with an 81-g weight drop from 152 or 183 cm. CSDs were detected with minimally invasive visible light optical intrinsic signal imaging. Cerebral blood flow index (CBFi) was measured in the 152-cm drop height cohort using diffuse correlation spectroscopy at baseline before and 4 min after CHI. Cognitive outcomes were assessed at 152- and 183-cm drop heights for the Morris water maze hidden platform, probe, and visible platform tests. RESULTS: CSDs occurred in 43% (n = 12 of 28) of 152-cm and 58% (n = 15 of 26) of 183-cm drop height CHI mice (p = 0.28). A lower baseline preinjury CBFi was associated with development of CSDs in CHI mice (1.50 ± 0.07 × 10-7 CHI without CSD [CSD-] vs. 1.17 ± 0.04 × 10-7 CHI with CSD [CSD+], p = 0.0001). Furthermore, in CHI mice that developed CSDs, the ratio of post-CHI to pre-CHI CBFi was lower in the hemisphere ipsilateral to a CSD compared with non-CSD hemispheres (0.19 ± 0.07 less in the CSD hemisphere, p = 0.028). At a 152-cm drop height, there were no detectable differences between sham injured (n = 10), CHI CSD+ (n = 12), and CHI CSD- (n = 16) mice on Morris water maze testing at 4 weeks. At a 183-cm drop height, CHI CSD+ mice had worse performance on the hidden platform test at 1-2 weeks versus sham mice (n = 15 CHI CSD+, n = 9 sham, p = 0.045), but there was no appreciable differences compared with CHI CSD- mice (n = 11 CHI CSD-). CONCLUSIONS: The data suggest that a lower baseline cerebral blood flow prior to injury may contribute to the occurrence of a CSD. Furthermore, a CSD at the time of injury can be associated with worse cognitive outcome under the appropriate experimental conditions in a mouse CHI model of TBI.
BACKGROUND: Cortical spreading depolarizations (CSDs) are associated with worse outcomes in many forms of acute brain injury, including traumatic brain injury (TBI). Animal models could be helpful in developing new therapies or biomarkers to improve outcomes in survivors of TBI. Recently, investigators have observed CSDs in murine models of mild closed head injury (CHI). We designed the currently study to determine additional experimental conditions under which CSDs can be observed, from mild to relatively more severe TBI. METHODS: Adult male C57Bl/6J mice (8-14 weeks old) were anesthetized with isoflurane and subjected to CHI with an 81-g weight drop from 152 or 183 cm. CSDs were detected with minimally invasive visible light optical intrinsic signal imaging. Cerebral blood flow index (CBFi) was measured in the 152-cm drop height cohort using diffuse correlation spectroscopy at baseline before and 4 min after CHI. Cognitive outcomes were assessed at 152- and 183-cm drop heights for the Morris water maze hidden platform, probe, and visible platform tests. RESULTS: CSDs occurred in 43% (n = 12 of 28) of 152-cm and 58% (n = 15 of 26) of 183-cm drop height CHI mice (p = 0.28). A lower baseline preinjury CBFi was associated with development of CSDs in CHI mice (1.50 ± 0.07 × 10-7 CHI without CSD [CSD-] vs. 1.17 ± 0.04 × 10-7 CHI with CSD [CSD+], p = 0.0001). Furthermore, in CHI mice that developed CSDs, the ratio of post-CHI to pre-CHI CBFi was lower in the hemisphere ipsilateral to a CSD compared with non-CSD hemispheres (0.19 ± 0.07 less in the CSD hemisphere, p = 0.028). At a 152-cm drop height, there were no detectable differences between sham injured (n = 10), CHI CSD+ (n = 12), and CHI CSD- (n = 16) mice on Morris water maze testing at 4 weeks. At a 183-cm drop height, CHI CSD+ mice had worse performance on the hidden platform test at 1-2 weeks versus sham mice (n = 15 CHI CSD+, n = 9 sham, p = 0.045), but there was no appreciable differences compared with CHI CSD- mice (n = 11 CHI CSD-). CONCLUSIONS: The data suggest that a lower baseline cerebral blood flow prior to injury may contribute to the occurrence of a CSD. Furthermore, a CSD at the time of injury can be associated with worse cognitive outcome under the appropriate experimental conditions in a mouse CHI model of TBI.
Authors: Erin M Buckley; Benjamin F Miller; Julianne M Golinski; Homa Sadeghian; Lauren M McAllister; Mark Vangel; Cenk Ayata; William P Meehan; Maria Angela Franceschini; Michael J Whalen Journal: J Cereb Blood Flow Metab Date: 2015-07-08 Impact factor: 6.200
Authors: Hiroaki Sakai; Huaxin Sheng; Robert B Yates; Kazuyoshi Ishida; Robert D Pearlstein; David S Warner Journal: Anesthesiology Date: 2007-01 Impact factor: 7.892
Authors: Katelyn M Reinhart; Alanna Humphrey; K C Brennan; Andrew P Carlson; C William Shuttleworth Journal: Neurocrit Care Date: 2021-10-17 Impact factor: 3.210
Authors: Rebekah Mannix; William P Meehan; Joseph Mandeville; Patricia E Grant; Tory Gray; Jacqueline Berglass; Jimmy Zhang; John Bryant; Shervin Rezaie; Joon Yong Chung; Nicholas V Peters; Christopher Lee; Lee W Tien; David L Kaplan; Mel Feany; Michael Whalen Journal: Ann Neurol Date: 2013-08-06 Impact factor: 10.422
Authors: C William Shuttleworth; R David Andrew; Yama Akbari; Cenk Ayata; Ramani Balu; K C Brennan; Martyn Boutelle; Andrew P Carlson; Jens P Dreier; Martin Fabricius; Eszter Farkas; Brandon Foreman; Raimund Helbok; Nils Henninger; Sharon L Jewell; Stephen C Jones; Sergei A Kirov; Britta E Lindquist; Carolina B Maciel; David Okonkwo; Katelyn M Reinhart; R Meldrum Robertson; Eric S Rosenthal; Tomas Watanabe; Jed A Hartings Journal: Neurocrit Care Date: 2020-02 Impact factor: 3.210
Authors: Raimund Helbok; Jed A Hartings; Alois Schiefecker; Baptiste Balança; Sharon Jewel; Brandon Foreman; Ari Ercole; Ramani Balu; Cenk Ayata; Laura Ngwenya; Eric Rosenthal; Martyn G Boutelle; Eszter Farkas; Jens P Dreier; Martin Fabricius; C William Shuttleworth; Andrew Carlson Journal: Neurocrit Care Date: 2020-02 Impact factor: 3.210
Authors: Alexis N Simpkins; Katharina M Busl; Edilberto Amorim; Carolina Barnett-Tapia; Mackenzie C Cervenka; Monica B Dhakar; Mark R Etherton; Celia Fung; Robert Griggs; Robert G Holloway; Adam G Kelly; Imad R Khan; Karlo J Lizarraga; Hannah G Madagan; Chidinma L Onweni; Humberto Mestre; Alejandro A Rabinstein; Clio Rubinos; Dawling A Dionisio-Santos; Teddy S Youn; Lisa H Merck; Carolina B Maciel Journal: Neurocrit Care Date: 2020-09-21 Impact factor: 3.210